Biomarin Pharmaceutical (BMRN) Tax Rate Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) Tax Rate Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn |
| 10 | Biomarin Pharmaceutical | 11.72 Bn | 9.50 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,486.00 |
| Dec 31, 2025 | -17,010.00 |
| Sep 30, 2025 | 23,258.00 |
| Jun 30, 2025 | -137.00 |
| Mar 31, 2025 | 1,203.00 |
| Dec 31, 2024 | 1,332.00 |
| Sep 30, 2024 | 16.00 |
| Jun 30, 2024 | 1,031.00 |
| Mar 31, 2024 | -922.00 |
| Dec 31, 2023 | -14,176.00 |
| Sep 30, 2023 | -137,892.00 |
| Jun 30, 2023 | -1,011.00 |
| Mar 31, 2023 | -930.00 |
| Dec 31, 2022 | -15,502.00 |
| Sep 30, 2022 | 21,096.00 |
| Jun 30, 2022 | 998.00 |
| Mar 31, 2022 | 1,662.00 |
| Dec 31, 2021 | -7,854.00 |
| Sep 30, 2021 | -1,405.00 |
| Jun 30, 2021 | -3,386.00 |